Monoclonal Antibodies

Companies Monoclonal Antibodies

Santa Cruz Biotechnology, Inc., USA

Santa Cruz Biotechnology, Inc. is focused on the ongoing development of research antibodies. It is our goal to continue to offer the broadest range of research reagents in the field. We provide superior, innovative primary antibodies and support products. We are the leading worldwide source of prod more

Becton Dickinson GmbH, Germany

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. We are focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and pr more

IBA GmbH, Germany

IBA GmbH – Solutions For Life Sciences Being one of the foremost providers of tag-derived products and services IBA GmbH is covering the entire production process of recombinant proteins including cloning, transfection, protein expression and purification to detection, assay and immobilization. "S more

Products Monoclonal Antibodies

High Performance Crossflow Cassettes Sartocon® ECO with Hydrosart® membrane

Sartocon® ECO is based on Hydrosart® ultrafilter technology that uses cross linked polymer membranes based on hydrophilic cellulose more

Increase throughput and robustness of your antibody purification

TOYOPEARL AF-rProtein A affinity resin is well-suited for capturing of antibodies out of high titre feedstocks more

Catalogues Monoclonal Antibodies

Fat Cells, Immune Cells and Metabolic Syndrome

The Importance of the research into Metabolic Syndrome and related diseases is fascinating. Which methods and tools do experts use? more

Videos Monoclonal Antibodies

Increase throughput and robustness of your antibody purification

TOYOPEARL AF-rProtein A-650F combines a high binding capacity at short residence time and fast mass transfer kinetics with alkaline stability. Protein A based affinity chromatography is the industry standard for the capture of monoclonal antibodies (MAbs) in downstream processing. Rising fermentatio more

News Monoclonal Antibodies

• New safety test predicts reactions to novel drugs and cosmetics

  A simple lab-based skin test which eliminates the risk of adverse reactions to new drugs, cosmetics and household chemicals has been developed by a Newcastle University, UK team. It uses real human skin and immune cells to show any reaction such as a rash or blistering indicating a wider immune resp more

• arGEN-X initiates Phase Ib study of ARGX-110 in cancer

  arGEN-X announced the initiation of a Phase Ib first-in-man cancer study with ARGX-110, its first SIMPLE Antibody™ program to enter the clinic in just three years from initiation of discovery. ARGX-110 is a first-in-class CD70-targeting monoclonal antibody that addresses both known mechanisms of act more

• Adocia is extending its intellectual property to new formulations of monoclonal antibodies

  Adocia announced that it has filed another three patent applications covering new formulations of monoclonal antibodies. More specifically, these patent applications relate to original formulations that facilitate the subcutaneous administration of antibodies, as well as formulations that reduce ant more

White papers Monoclonal Antibodies

• Eternal shelf-life for ELISA?
  

  Reliable long-term stabilization of immunoassay components is beneficial in many applications. Stabilization and storage of components are important for effective workflows not only for performing large numbers of ELISA but also for medium and small numbers of ELISA. This article deals with the state of the art - particularly with regard to food, veterinary or clinical diagnostics. Clinical immuno diagnostics require adequate stabilization of assay components according to EU guidance (IVDD 98/79/EC) or corresponding international regulations before launch. more

• Characterizing Biotherapeutics with HPLC
  

  As demonstrated here, there are a broad range of HPLC applications used in development, production, validation and release of protein therapeutics for human use. Some of the applications mentioned above are mandatory when submitting a new biopharmaceutical to approval at the regulatory agencies. The introduction of the first so-called biosimilars in Europe further increased the demand for highly efficient analysis methods. The continuous development of new stationary phases for the common modes of biochromatography, such as size exclusion, ion exchange and hydrophilic interaction chromatography support biochemists in increasing lab productivity and establishing high-throughput HPLC analysis not only for small molecules but also for large biopolymers more

Publications Monoclonal Antibodies

• Development and characterization of a specific IgG monoclonal antibody toward the Lewis x antigen using splenocytes of Schistosoma mansoni-infected mice

  The parasitic blood fluke Schistosoma mansoni synthesizes immunogenic glycans containing the human Lewis x antigen (Lex; Galactose-β1-4(Fucα1-3)N-acetylglucosamine-β-R, also called CD15), but the biological role(s) of this antigen in the parasites and in humans is poorly understood. To develop IgG- more

• Targeting ROR1 Inhibits Epithelial–Mesenchymal Transition and Metastasis

  Metastasis is responsible for 90% of cancer-related deaths. Strategies are needed that can inhibit the capacity of cancer cells to migrate across the anatomic barriers and colonize distant organs. Here, we show an association between metastasis and expression of a type I receptor tyrosine kinase–lik more

• Systemic Administration of Abeta mAb Reduces Retinal Deposition of Abeta and Activated Complement C3 in Age-Related Macular Degeneration Mouse Model

  by Ian Catchpole, Volker Germaschewski, Jaimie Hoh Kam, Peter Lundh von Leithner, Susannah Ford, Gerald Gough, Peter Adamson, Philip Overend, Jan Hilpert, Francisco J. López, Yin Shan Eric Ng, Pete Coffey, Glen Jeffery Age-related macular degeneration (AMD) is a leading cause of legal blindness i more

Market studies Monoclonal Antibodies

• iBio, Inc. (NYSE ) - Financial and Strategic SWOT Analysis Review

  iBio, Inc. (iBio, formerly iBioPharma, Inc.) is a biotechnology company, engaged in the development of vaccines and therapeutic proteins based on its plant-based iBioLaunch platform technology, which is used in the manufacture of biopharmaceuticals. Its products include influenza vaccines, biodefenc more

• Medical & Biological Laboratories Co., Ltd. - Strategic SWOT Analysis Review

  Medical & Biological Laboratories Co., Ltd.(MBL) is engaged in the research, development and manufacture of clinical reagents and basic research reagents. It products are marketed to hospitals, research institutions and clinical testing centers. Its subsidiaries include MBL International (MBLI) and more

• Gliatech Inc. - Strategic SWOT Analysis Review

  Gliatech Inc. (Gliatech) is principally engaged in the discovery and development of biosurgery and pharmaceutical products. The company's biosurgery product portfolio includes Adcon-T/N, Adcon-L and Adcon Solution. These products are proprietary, restorable, carbohydrate polymer medical devices that more

Websites Monoclonal Antibodies